Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe
Само за регистроване кориснике
2023
Аутори
Stelzle, DominikAbraham, Annette
Kaminski, Miriam
Schmidt, Veronika
De Meijere, Robert
Bustos, Javier A
Garcia, Hector Hugo
Sahu, Priyadarshi Soumyaranjan
Bobić, Branko
Cretu, Carmen
Chiodini, Peter
Dermauw, Veronique
Devleesschauwer, Brecht
Dorny, Pierre
Fonseca, Ana
Gabriël, Sarah
Morales, Maria Ángeles Gómez
Laranjo-González, Minerva
Hoerauf, Achim
Hunter, Ewan
Jambou, Ronan
Jurhar-Pavlova, Maja
Reiter-Owona, Ingrid
Sotiraki, Smaragda
Trevisan, Chiara
Vilhena, Manuela
Walker, Naomi F
Zammarchi, Lorenzo
Winkler, Andrea Sylvia
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Objectives: Neurocysticercosis (NCC) is a parasitic disease caused by the larval stage of the tapeworm Taenia solium. NCC mainly occurs in Africa, Latin America and South-East Asia and can cause a variety of clinical
signs/symptoms. Although it is a rare disease in Europe, it should nonetheless be considered as a differential
diagnosis. The aim of this study was to describe clinical characteristics and management of patients with NCC
diagnosed and treated in Europe.
Methods: We conducted a systematic search of published and unpublished data on patients diagnosed with NCC
in Europe (2000–2019) and extracted demographic, clinical and radiological information on each case, if available. Results: Out of 293 identified NCC cases, 59% of patients presented initially with epileptic seizures (21% focal onset); 52% presented with headache and 54% had other neurological signs/symptoms. The majority of patients had a travel or migration history (76%), mostly from/to Latin America (38%), Afri...ca (32%) or Asia (30%). Treatment varied largely depending on cyst location and number. The outcome was favorable in 90% of the cases.
Conclusions: Management of NCC in Europe varied considerably but often had a good outcome. Travel and
migration to and from areas endemic for T. solium will likely result in continued low prevalence of NCC in Europe.Therefore, training and guidance of clinicians is recommended for optimal patient management.
Кључне речи:
Neurocysticercosis / Taenia solium / Europe / neglected tropical diseases / NCC management / Global Health / Clinical epidemiology / One HealthИзвор:
Journal of Travel Medicine, 2023, 30, 1, taac102-Издавач:
- Oxford University Press
Финансирање / пројекти:
- German Federal Ministry of Educationand Research (BMBF) [mainly SOLID project (01KA1617)
- CYSTINET-Africa project (01KA2112B)
- ‘Short Term Scientific Mission’ grant CYSTINET (CostAction TD1302)
- University College London Hospitals Biomedical Research Centre
- UK National Institute for Health Research (NIHR) Academic Clinical Lecturership
- German Federal Ministry of Education and Research (BMBF) [The LancetOne Health Commission 01KA1912]
Институција/група
Institut za medicinska istraživanjaTY - JOUR AU - Stelzle, Dominik AU - Abraham, Annette AU - Kaminski, Miriam AU - Schmidt, Veronika AU - De Meijere, Robert AU - Bustos, Javier A AU - Garcia, Hector Hugo AU - Sahu, Priyadarshi Soumyaranjan AU - Bobić, Branko AU - Cretu, Carmen AU - Chiodini, Peter AU - Dermauw, Veronique AU - Devleesschauwer, Brecht AU - Dorny, Pierre AU - Fonseca, Ana AU - Gabriël, Sarah AU - Morales, Maria Ángeles Gómez AU - Laranjo-González, Minerva AU - Hoerauf, Achim AU - Hunter, Ewan AU - Jambou, Ronan AU - Jurhar-Pavlova, Maja AU - Reiter-Owona, Ingrid AU - Sotiraki, Smaragda AU - Trevisan, Chiara AU - Vilhena, Manuela AU - Walker, Naomi F AU - Zammarchi, Lorenzo AU - Winkler, Andrea Sylvia PY - 2023 UR - http://rimi.imi.bg.ac.rs/handle/123456789/1320 AB - Objectives: Neurocysticercosis (NCC) is a parasitic disease caused by the larval stage of the tapeworm Taenia solium. NCC mainly occurs in Africa, Latin America and South-East Asia and can cause a variety of clinical signs/symptoms. Although it is a rare disease in Europe, it should nonetheless be considered as a differential diagnosis. The aim of this study was to describe clinical characteristics and management of patients with NCC diagnosed and treated in Europe. Methods: We conducted a systematic search of published and unpublished data on patients diagnosed with NCC in Europe (2000–2019) and extracted demographic, clinical and radiological information on each case, if available. Results: Out of 293 identified NCC cases, 59% of patients presented initially with epileptic seizures (21% focal onset); 52% presented with headache and 54% had other neurological signs/symptoms. The majority of patients had a travel or migration history (76%), mostly from/to Latin America (38%), Africa (32%) or Asia (30%). Treatment varied largely depending on cyst location and number. The outcome was favorable in 90% of the cases. Conclusions: Management of NCC in Europe varied considerably but often had a good outcome. Travel and migration to and from areas endemic for T. solium will likely result in continued low prevalence of NCC in Europe.Therefore, training and guidance of clinicians is recommended for optimal patient management. PB - Oxford University Press T2 - Journal of Travel Medicine T1 - Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe IS - 1 SP - taac102 VL - 30 DO - 10.1093/jtm/taac102 ER -
@article{ author = "Stelzle, Dominik and Abraham, Annette and Kaminski, Miriam and Schmidt, Veronika and De Meijere, Robert and Bustos, Javier A and Garcia, Hector Hugo and Sahu, Priyadarshi Soumyaranjan and Bobić, Branko and Cretu, Carmen and Chiodini, Peter and Dermauw, Veronique and Devleesschauwer, Brecht and Dorny, Pierre and Fonseca, Ana and Gabriël, Sarah and Morales, Maria Ángeles Gómez and Laranjo-González, Minerva and Hoerauf, Achim and Hunter, Ewan and Jambou, Ronan and Jurhar-Pavlova, Maja and Reiter-Owona, Ingrid and Sotiraki, Smaragda and Trevisan, Chiara and Vilhena, Manuela and Walker, Naomi F and Zammarchi, Lorenzo and Winkler, Andrea Sylvia", year = "2023", abstract = "Objectives: Neurocysticercosis (NCC) is a parasitic disease caused by the larval stage of the tapeworm Taenia solium. NCC mainly occurs in Africa, Latin America and South-East Asia and can cause a variety of clinical signs/symptoms. Although it is a rare disease in Europe, it should nonetheless be considered as a differential diagnosis. The aim of this study was to describe clinical characteristics and management of patients with NCC diagnosed and treated in Europe. Methods: We conducted a systematic search of published and unpublished data on patients diagnosed with NCC in Europe (2000–2019) and extracted demographic, clinical and radiological information on each case, if available. Results: Out of 293 identified NCC cases, 59% of patients presented initially with epileptic seizures (21% focal onset); 52% presented with headache and 54% had other neurological signs/symptoms. The majority of patients had a travel or migration history (76%), mostly from/to Latin America (38%), Africa (32%) or Asia (30%). Treatment varied largely depending on cyst location and number. The outcome was favorable in 90% of the cases. Conclusions: Management of NCC in Europe varied considerably but often had a good outcome. Travel and migration to and from areas endemic for T. solium will likely result in continued low prevalence of NCC in Europe.Therefore, training and guidance of clinicians is recommended for optimal patient management.", publisher = "Oxford University Press", journal = "Journal of Travel Medicine", title = "Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe", number = "1", pages = "taac102", volume = "30", doi = "10.1093/jtm/taac102" }
Stelzle, D., Abraham, A., Kaminski, M., Schmidt, V., De Meijere, R., Bustos, J. A., Garcia, H. H., Sahu, P. S., Bobić, B., Cretu, C., Chiodini, P., Dermauw, V., Devleesschauwer, B., Dorny, P., Fonseca, A., Gabriël, S., Morales, M. Á. G., Laranjo-González, M., Hoerauf, A., Hunter, E., Jambou, R., Jurhar-Pavlova, M., Reiter-Owona, I., Sotiraki, S., Trevisan, C., Vilhena, M., Walker, N. F., Zammarchi, L.,& Winkler, A. S.. (2023). Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe. in Journal of Travel Medicine Oxford University Press., 30(1), taac102. https://doi.org/10.1093/jtm/taac102
Stelzle D, Abraham A, Kaminski M, Schmidt V, De Meijere R, Bustos JA, Garcia HH, Sahu PS, Bobić B, Cretu C, Chiodini P, Dermauw V, Devleesschauwer B, Dorny P, Fonseca A, Gabriël S, Morales MÁG, Laranjo-González M, Hoerauf A, Hunter E, Jambou R, Jurhar-Pavlova M, Reiter-Owona I, Sotiraki S, Trevisan C, Vilhena M, Walker NF, Zammarchi L, Winkler AS. Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe. in Journal of Travel Medicine. 2023;30(1):taac102. doi:10.1093/jtm/taac102 .
Stelzle, Dominik, Abraham, Annette, Kaminski, Miriam, Schmidt, Veronika, De Meijere, Robert, Bustos, Javier A, Garcia, Hector Hugo, Sahu, Priyadarshi Soumyaranjan, Bobić, Branko, Cretu, Carmen, Chiodini, Peter, Dermauw, Veronique, Devleesschauwer, Brecht, Dorny, Pierre, Fonseca, Ana, Gabriël, Sarah, Morales, Maria Ángeles Gómez, Laranjo-González, Minerva, Hoerauf, Achim, Hunter, Ewan, Jambou, Ronan, Jurhar-Pavlova, Maja, Reiter-Owona, Ingrid, Sotiraki, Smaragda, Trevisan, Chiara, Vilhena, Manuela, Walker, Naomi F, Zammarchi, Lorenzo, Winkler, Andrea Sylvia, "Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe" in Journal of Travel Medicine, 30, no. 1 (2023):taac102, https://doi.org/10.1093/jtm/taac102 . .